Quantel Medical Receives FDA Clearance for Ophthalmic Laser System

Quantel Medical has announced it has received FDA clearance for an ophthalmic laser system, according to a news release (pdf).

Advertisement

 

The SupraScan 577 laser is designed to treat retinal diseases. The company says the system combines 577nm yellow wavelength, pattern-scanning and MicroPulse tissue-sparing laser emission modes.

 

“We are proud to have passed this regulatory milestone,” said Jean-Marc Gendre, CEO of Quantel Medical, in the release. “Quantel was the first company in the world to bring to market a solid-state green retina laser in 1993, followed by a solid-state yellow retina laser in 2008. Today’s announcement of 510(k) clearance for the SupraScan 577, the most advanced solidstate yellow scanning retina laser allows Quantel USA to offer a market-changing solution to retina specialists in the United States.”

 

Quantel Medical is headquartered in France.

 

Related Articles on FDA Clearances:

Teleflex Receives FDA Clearance Vascular Access Catheter

Avinger Receives FDA Clearance for Optical Coherence Tomography Catheter

LDR Receives FDA Conditional Approval for Cervical Disc

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.